Skip to content

OTC · CIK 0001965052

MGTE Marblegate Capital Corp

Insider trading from SEC Form 4. Last filing Apr 21, 2025.

In brief

Marblegate Capital Corp (MGTE) has 7 SEC Form 4 filings on file from 4 insiders, the latest filed on Apr 21, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company

Signals

Open-market buys and sells at Marblegate Capital Corp, scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

Every row filed, 31 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Apr 17, 2025Paul Arrouet
President
DDisposition to issuer
Common Stockindirect: See footnotes
-5,289,072--0Apr 21, 2025
Apr 17, 2025Harvey Golub
director
AGrant or award
Common Stockindirect: See footnote
+23,028--304,673Apr 21, 2025
Apr 17, 2025Andrew Milgram
Chief Executive Officer
DDisposition to issuer
Common Stockindirect: See footnotes
-5,289,072--0Apr 21, 2025
Apr 17, 2025Paul Arrouet
President
AGrant or award
Common Stockindirect: See footnotes
+3,878,216--13,556,794Apr 21, 2025
Apr 17, 2025Harvey Golub
director
AGrant or award
Warrants (right to buy)derivativeindirect: See footnote
+12,018$0.00$012,018Apr 21, 2025
Apr 17, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stockindirect: See footnotes
+3,878,216--13,556,794Apr 21, 2025
Apr 17, 2025Paul Arrouet
President
AGrant or award
Common Stockindirect: See footnotes
+843,947--10,424,568Apr 21, 2025
Apr 17, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stockindirect: See footnotes
+843,947--10,424,568Apr 21, 2025
Apr 17, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Warrantsderivativeindirect: See Footnotes
+165,463--165,463Apr 21, 2025
Apr 17, 2025Paul Arrouet
President
AGrant or award
Warrants (right to buy)derivativeindirect: See footnotes
+165,463$0.00$0165,463Apr 21, 2025
Apr 7, 2025Paul Arrouet
President
AGrant or award
Common Stock
+450--450Apr 8, 2025
Apr 7, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stock
+450--450Apr 8, 2025
Apr 7, 2025Jeffrey Kravetz
Chief Financial Officer
AGrant or award
Common Stock
+400--400Apr 8, 2025
Apr 7, 2025Harvey Golub
director
AGrant or award
Common Stockindirect: See footnotes
+450--450Apr 8, 2025
Apr 7, 2025Paul Arrouet
President
AGrant or award
Common Stockindirect: See footnotes
+5,289,072--5,289,072Apr 8, 2025
Apr 7, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stockindirect: See footnotes
+5,289,072--5,289,072Apr 8, 2025
Apr 7, 2025Harvey Golub
director
AGrant or award
Common Stockindirect: See footnotes
+281,645--281,645Apr 8, 2025
Apr 7, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stockindirect: See footnotes
+9,678,578--9,678,578Apr 8, 2025
Apr 7, 2025Paul Arrouet
President
AGrant or award
Common Stockindirect: See footnotes
+9,678,578--9,678,578Apr 8, 2025
Apr 7, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stockindirect: See footnotes
+13,793,655--13,793,655Apr 8, 2025
Apr 7, 2025Paul Arrouet
President
AGrant or award
Common Stockindirect: See footnotes
+13,793,655--13,793,655Apr 8, 2025
Apr 7, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stockindirect: See footnotes
+8,660,253--8,660,253Apr 8, 2025
Apr 7, 2025Paul Arrouet
President
AGrant or award
Common Stockindirect: See footnotes
+8,660,253--8,660,253Apr 8, 2025
Apr 7, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stockindirect: See footnotes
+9,580,621--9,580,621Apr 8, 2025
Apr 7, 2025Paul Arrouet
President
AGrant or award
Common Stockindirect: See footnotes
+9,580,621--9,580,621Apr 8, 2025
Apr 7, 2025Paul Arrouet
President
AGrant or award
Common Stockindirect: See footnotes
+17,293,702--17,293,702Apr 8, 2025
Apr 7, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stockindirect: See footnotes
+17,293,702--17,293,702Apr 8, 2025
Apr 7, 2025Paul Arrouet
President
AGrant or award
Common Stockindirect: See footnotes
+1,317,244--1,317,244Apr 8, 2025
Apr 7, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stockindirect: See footnotes
+1,317,244--1,317,244Apr 8, 2025
Apr 7, 2025Paul Arrouet
President
AGrant or award
Common Stockindirect: See footnotes
+2,630,411--2,630,411Apr 8, 2025
Apr 7, 2025Andrew Milgram
Chief Executive Officer
AGrant or award
Common Stockindirect: See footnotes
+2,630,411--2,630,411Apr 8, 2025

Insiders

Everyone who has filed a Form 4 here.

Questions about MGTE

Answered from the filings on this page, as of the latest one.

Are insiders buying MGTE?

No. In the last 90 days no insider at Marblegate Capital Corp bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade MGTE on the open market?

No open-market trade has been scored at Marblegate Capital Corp. The latest Form 4 on file was filed on Apr 21, 2025 and holds grants, exercises or other rows that are not market trades.

How many insiders file Form 4 at Marblegate Capital Corp?

4 people have filed a Form 4 at Marblegate Capital Corp, among them Paul Arrouet (President), Harvey Golub (director), Jeffrey Kravetz (Chief Financial Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

MGTE insider trading: Marblegate Capital Corp | InsiderTell